In addition, BTG1 is an anti-proliferative gene that is frequently mutated in B cell lymphomas (47), while GAPDH participates in glycolysis which displays greater activity during inflammation (48). This evidence concerns the gene GAPDH and B-cell non-Hodgkin lymphoma.